Abstract
The aim of this study is to produce the smart hydrogel to use insulin release for human body. p(HEMA-co-Eudragit L-100) hydrogels containing different ratios of 2-Hydroxyethyl methacrylate (HEMA) and Eudragait L-100 were synthesized by using ammonium persulfate (APS) as an initiator and ethylene glycol dimethacrylate (EGDMA) as a cross linker. The structures of hydrogels produced were characterized by using Fourier Transform Infrared Spectroscopy (FT-IR) and Scanning electron microscope (SEM) analysis. In this way, optimum synthesis conditions were determined for p(HEMA-co-Eudragit L-100) hydrogels by using Taguchi method as an optimization method. The gelling percentages of all hydrogels were calculated. After all, the swelling behaviors (%) of hydrogels were investigated in range of various times (1–44 hrs), temperatures (20–50°C) and pH (2–12) and the optimum process conditions in the production of hydrogels were determined. Consequently, the optimum time, temperature and pH were 24 hours, 37°C and 7, respectively. Thus, this hydrogel could be evaluated in insulin release for diabetes treatment and drug industry.
Get full access to this article
View all access options for this article.
